RecruitingPhase 3NCT05723198
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Baricitinib(drug)
- Enrollment
- 595 enrolled
- Eligibility
- 6-17 years · All sexes
- Timeline
- 2023 – 2029
Study locations (30)
- Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Investigate MD, Scottsdale, Arizona, United States
- California Dermatology & Clinical Research Institute, Encinitas, California, United States
- Dermatology Research Associates, Los Angeles, California, United States
- University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego, California, United States
- The Permanente Medical Group, Inc., San Francisco, California, United States
- Southern California Dermatology, Inc., Santa Ana, California, United States
- Dermatology Physicians of Connecticut, Fairfield, Connecticut, United States
- Skin Care Research, Inc, Boca Raton, Florida, United States
- Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, United States
- D&H Doral Research Center LLC, Doral, Florida, United States
- Skin Care Research, Inc, Hollywood, Florida, United States
- Solutions Through Advanced Research, Inc., Jacksonville, Florida, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05723198 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC